Integrative ChIP-seq/Microarray Analysis Identifies a CTNNB1 Target Signature Enriched in Intestinal Stem Cells and Colon Cancer

• Kazuhide Watanabe,

  Affiliation Department of Biological Chemistry, School of Medicine, University of California Irvine, Irvine, California, United States of America

  ⨯
• Jacob Biesinger,

  Affiliations Institute for Genomics and Bioinformatics, University of California Irvine, Irvine, California, United States of America, Department of Computer Science, University of California Irvine, Irvine, California, United States of America

  ⨯
• Michael L. Salmans,

  Affiliation Department of Biological Chemistry, School of Medicine, University of California Irvine, Irvine, California, United States of America

  ⨯
• Brian S. Roberts,

  Affiliation Rosetta Inpharmatics, LLC, Merck & Co Inc., Seattle, Washington, United States of America

  ⨯
• William T. Arthur,

  Affiliation Rosetta Inpharmatics, LLC, Merck & Co Inc., Seattle, Washington, United States of America

  ⨯
• Michele Cleary,

  Affiliation Rosetta Inpharmatics, LLC, Merck & Co Inc., Seattle, Washington, United States of America

  ⨯
• Bogi Andersen,

  Affiliation Department of Biological Chemistry, School of Medicine, University of California Irvine, Irvine, California, United States of America

  ⨯
• Xiaohui Xie,

  Affiliations Institute for Genomics and Bioinformatics, University of California Irvine, Irvine, California, United States of America, Department of Computer Science, University of California Irvine, Irvine, California, United States of America

  ⨯
• Xing Dai

  * E-mail: xdai@uci.edu

  Affiliations Department of Biological Chemistry, School of Medicine, University of California Irvine, Irvine, California, United States of America, Institute for Genomics and Bioinformatics, University of California Irvine, Irvine, California, United States of America

  ⨯